Iran, Islamic Republic of vs Israel: Immunization, Hib3
Iran, Islamic Republic of
98.0%
in 2024
Israel
98.0%
in 2024
Iran, Islamic Republic of rank
20th
Israel rank
20th
Immunization, Hib3 over time
- Iran, Islamic Republic of
- Israel
How they compare
Iran, Islamic Republic of currently reports 98.0% against 98.0% in Israel, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Iran, Islamic Republic of ahead.
Iran, Islamic Republic of ranks 20th and Israel ranks 20th of 191 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8% | 96.6% | 2.2% | Iran, Islamic Republic of |
| 2020s | 98.6% | 98.0% | 0.6% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Iran, Islamic Republic of or Israel?
- Iran, Islamic Republic of, at 98.0% against 98.0% in Israel as of 2024.
- What is the difference in immunization, hib3 between Iran, Islamic Republic of and Israel?
- 0.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Israel?
- 10 years are reported by both, from 2015 to 2024.
- How do Iran, Islamic Republic of and Israel rank globally for immunization, hib3?
- Iran, Islamic Republic of ranks 20th and Israel ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.